Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01225055 · ClinicalTrials.gov registry record · Phase 2
Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury
A Phase 2 study, sponsored by Thomas J. Schnitzer.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT01225055: Completed Phase 2 study, sponsored by Thomas J. Schnitzer.
NCT01225055 is a Phase 2 study that has completed, run by Thomas J. Schnitzer. The registered enrollment target is 60 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01225055, a Phase 2 study, has completed, sponsored by Thomas J. Schnitzer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
Spinal cord injury (SCI) results in marked acute loss of bone. This study evaluates the effect of teriparatide (PTH) and the use of vibration as a form of mechanical stimulation on bone mass.
Primary Outcome
The mean change in BMD of the total hip after 12 month of treatment
Interventions
- DRUG Teriparatide
- DEVICE vibration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-10 |
| Est. Completion | 2016-08 |
| Phase | Phase 2 |
What the finished NCT01225055 record still lists
NCT01225055 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 2 interventions - of which Teriparatide is the first listed.
NCT01225055 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01225055 about?
NCT01225055 is a clinical study titled "Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury". Spinal cord injury (SCI) results in marked acute loss of bone. This study evaluates the effect of teriparatide (PTH) and the use of vibration as a form of mechanical stimulation on bone mass.
What is the current status of trial NCT01225055?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2010-10. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01225055?
The interventions under investigation include: Teriparatide (DRUG), vibration (DEVICE).
Who is sponsoring clinical trial NCT01225055?
This trial is sponsored by Thomas J. Schnitzer, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01225055's enrollment target sits among peer trials
60 1027th of 2000 higher than 868 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia